Blog

The below Parliamentary question was asked by Baroness Deech on 2016-04-25.

To ask Her Majesty’s Government what is their assessment of the importance of the particular focus on Alzheimer’s and Type 1 Diabetes in the third Britain Israel Research and Academic Exchange Partnership Research Call.

Baroness Anelay of St Johns

The focus of the Britain Israel Research and Academic Exchange Partnership (BIRAX) Initiative is regenerative medicine, which can be applied to many fields of medical research. In addition to the regenerative medicine focus, the Initiative has supported more specific research areas, including Type 1 diabetes and neurodegenerative conditions. These areas have been identified as critical in both Israel and the UK, as well as globally, and as ones in which both countries have particular research expertise. The British Council works with leading research charities in the UK and globally, including British Heart Foundation, Juvenile Diabetes Research Foundation, Multiple Sclerosis Society and Parkinson UK to provide mutual funding, and these areas have been highlighted as areas of joint interest. However it is important to note that it is the quality of the science that drives the BIRAX selection process, and that applications which do not come under these priorities but do meet the criteria have also been selected for funding in past calls. The third call for proposals will continue to evaluate proposals according to criteria outlined in the call’s guidelines and their scientific excellence.

The focus on Alzheimer’s and Type 1 Diabetes has the potential to bring upwards of £1.6 million additional funding (to add to the £7 million existing funding raised by the Initiative) to collaborative projects, of which at least 50 per cent is for use in UK universities.

The below Parliamentary question was asked by Baroness Deech on 2016-04-25.

To ask Her Majesty’s Government what assessment they have made of the effectiveness of the stem cell research collaboration between British and Israeli scientists under the auspices of the Britain Israel Research and Academic Exchange Partnership.

Baroness Anelay of St Johns

The effectiveness of the Britain Israel Research and Academic Exchange Partnership (BIRAX) comes firstly from its robust selection process. All projects are assessed during the selection process for their quality of science and contribution to the scientific community by a selection panel of leading researchers in their field from the UK and Israel, and also by an anonymous peer review process, that includes leading researchers around the world. During their implementation, projects are monitored via yearly narrative and financial reporting, in addition to reporting on Researchfish. The British Council is planning a comprehensive evaluation exercise this year, which is the programme’s 5th year.

In addition, the programme is being co-funded by leading health research organisations such as British Heart Foundation, Juvenile Diabetes Research Foundation, Multiple Sclerosis Society and Parkinson’s UK, who evaluate the projects before making their funding commitment and ensure their scientific excellence.

While the projects are too recent to be assessed for their impact on the Regenerative Medicine scientific field, so far a number of publications have emanated from the programme, including a ground-breaking article in Cell by Professor Yaqub Hanna in collaboration with Professor Azim Surani from The University of Cambridge. The article was assessed by the journal to be their number one paper last year. Articles by BIRAX grantees have also been published in Nature, Cell Biology, Frontiers in Immunology, Cancer Stem Cells and International Innovation.

The Programme is the only platform for bilateral cooperation between Israel and UK researchers in the field of regenerative medicine and stem cell research. Over 30 labs are involved in the projects, and hundreds of scientists are working on the Programme’s project. Over 1000 scientists took part in the bi-annual BIRAX conferences, with the recent conference which took place at the University of Oxford, this April being the largest.

The below Parliamentary question was asked by Baroness Deech on 2016-04-25.

To ask Her Majesty’s Government what assessment they have made of the effectiveness of the Middle East water research programme as a vehicle for collaboration between researchers in the UK, Israel and the Middle East.

Baroness Anelay of St Johns

The Science and Innovation network and the British Council in Israel manage the Trilateral Water Research programme, which was launched in 2015. The effectiveness of the programme as a platform for cross border research can be measured by the fact that five research projects have been launched involving leading researchers in the water research field from Israel, the Occupied Palestinian Territories, Gaza, Morocco, Jordan and the UK. The projects look at varied aspects of water management in the region and seek to provide innovative solutions while cementing links between academic institutions and facilitating cutting-edge research.

The programme is subject to monitoring and evaluation procedures in two stages. The first is the selection process for acceptance into the programme and receipt of a research grant. This process is a robust academic selection mechanism involving scientific peer review and is managed centrally by the British Council’s London Institutional Links team in accordance with the procedures that govern the wider Global Institutional Links programme.

The second stage of monitoring and evaluation will be during project implementation. Projects will be monitored via narrative and financial reporting, in addition to reporting on Researchfish, the British Council’s chosen research evaluation platform. Projects were contracted and finance awarded in April 2016 so reports are not yet available.